Organization Overview
Historical Acquisition Tree
Alternative names
abiraterone (zytiga) (1993)
crotalidae polyvalent immune fab (ovine) (CroFab) (2000 NDA)
digoxin immune fab (ovine) (DigiFab) (2001)
glucarpidase (voraxaze) (2012)
hydroxocobalamin (cyanokit) (2006)
polidocanol (asclera) (2013)
potassium iodide (thyro-block) (2002)
uridine (2015)
Key: BTG (2) Acquired (1)
Key: BTG (1) Acquired (3)
Key: BTG (11) Acquired (11)
cisplatin (platinol) (1 trial)
digoxin immune fab (ovine) (DigiFab) (1 trial)
doxorubicin (Doxil) (2 trials)
Key: BTG (6) Acquired (2)
Adenocarcinoma (Phase 2)
Brain Neoplasms (Phase 2)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Cardiovascular Diseases (Phase 2)
Cerebral Hemorrhage (Phase 2)
Diabetes Mellitus (Phase 1)
Diabetes Mellitus, Type 2 (Phase 1)
Eclampsia (Phase 2)
Esophageal Neoplasms (Phase 2)
Gastroesophageal Reflux (Phase 4)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Hemoptysis (Phase 1)
Hemorrhage (Phase 2)
Hyperplasia (Phase 1)
Hypertension (Phase 2)
Leg Ulcer (Phase 4)
Lice Infestations (Phase 2)
Liver Neoplasms (Phase 1)
Migraine Disorders (Phase 2)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Neoplasms (Phase 2)
Neuroendocrine Tumors (Phase 2)
Osteosarcoma (Phase 2)
Parasitic Diseases (Phase 2)
Pre-Eclampsia (Phase 2)
Prostatic Hyperplasia (Phase 1)
Sclerosis (Phase 2)
Snake Bites (Phase 4)
Ulcer (Phase 4)
Varicose Ulcer (Phase 4)
Varicose Veins (Phase 4)